Division of Rheumatology
USF Health

Publications

Published Books or Book Chapters | Abstracts Presented/Published

  1. Carter JD, Cutolo EP, Behnke RH, Adelman HM. Pulmonary Infiltrates in an Elderly Man. Hospital Practice. 34(8):21-4,1999.
  2. Carter JD, Kanik KS, Valeriano J. Neck Mass in a Rheumatoid Arthritis Patient Taking Etanercept. Journal of Clinical Rheumatology. 6(2):80-1, 2000.
  3. Carter JD, Vasey FB, Valeriano-Marcet J, Kanik KS. “G” Stands for Gout. Arthritis and Rheumatism. 43(6):1418, 2000.
  4. Carter JD, Kanik KS, Vasey FB, Valeriano-Marcet J. Dermatomyositis with Normal Creatine Kinase and Elevated Aldolase Levels (letter). Journal of Rheumatology. 28(10):2366-7, 2001.
  5. Carter JD, Vasey FB, Kanik KS, Valeriano-Marcet. Polymyalgia Rheumatica and Temporal Arteritis with Sacroiliitis and Osteitis Pubis. Journal of Clinical Rheumatology. 7(4):261-4, 2001.
  6. Carter JD, Valeriano-Marcet J, Kanik KS, Vasey FB. ANA Negative Drug Induced Lupus Caused by Lisinopril. Southern Medical Journal. 94(11):1122-3, 2001.
  7. Carter JD, Vasey FB. Psoriatic Arthritis: Genetics, Immunology, and Therapies (Editorial). Journal of Clinical Rheumatology. 7(6):363-5, 2001.
  8. Carter JD, Valeriano J, Vasey FB. Reply to: Dermatomyositis with Normal Creatine Kinase and Elevated Aldolase Levels (letter). Journal of Rheumatology. 29(10):2242-3,2002.
  9. Valeriano J, Carter JD, Vasey FB. Soft Tissue Infections (Review). Rheumatic Disease Clinics of North America. 29(1):77-88, 2003.
  10. McIlwain L, Carter JD, Bin-Sagheer S, Vasey FB, Nord J. Hypersensitivity Vasculitis with Leukocytoclastic Vasculitis Secondary to Infliximab. Journal of Clinical Gastroenterology. 36(5):411-3, 2003.
  11. Carter JD, Warner E. Tumoral Calcinosis in a patient with Sarcoidosis. Arthritis & Rheumatism. 48(6):1770, 2003.
  12. Carter JD, Valeriano J, Vasey FB. A Case of Crohn’s Disease Worsened by Anakinra. Journal of Clinical Rheumatology. 9(4):275-6, 2003.
  13. Carter JD, Bognar B, Valeriano J, Vasey FB. Refractory neurosarcoidosis: a dramatic response to Infliximab. American Journal of Medicine. 117(4):277-9, 2004.
  14. Carter JD, Valeriano J, Vasey FB. A Prospective, Randomized 9-Month Comparison of Doxycycline vs. Doxycycline and Rifampin in Undifferentiated Spondyloarthropathy – with Special Reference to Chlamydia-Induced Arthritis. Journal of Rheumatology. 31(10):1973-80, 2004.
  15. Lodhi A, Carter JD, Valeriano J, Vasey FB. Can We Classify Psoriatic Arthritis? (editorial). Seminars in Arthritis & Rheumatism. 34(3):571-2, 2004.
  16. Carter JD. Treatment of Relapsing Polychondritis with a Tumor Necrosis Factor Inhibitor. Journal of Rheumatology. 32(7):1413, 2005.
  17. Carter JD, Valeriano J, Vasey FB. Antimicrobials for the Treatment of Chlamydia-Induced Reactive Arthritis. Annals of the Rheumatic Diseases. 64(3):512-3, 2005.
  18. Carter JD, Valeriano J, Vasey FB. Tumor Necrosis Factor Inhibition and VATER Association: A Causal Relationship? Journal of Rheumatology. 33(5):1014-7, 2006.
  19. Cruse LM, Valeriano J, Vasey FB, Carter JD. Prevalence of Evaluation and Treatment of Glucocorticoid-Induced Osteoporosis in Men Hospital. Journal of Clinical Rheumatology. 12(5):221-5, 2006.
  20. Carter JD, Valeriano J, Vasey FB. Hydroxychloroquine as a Treatment for Atrophoderma of Pasini and Pierini. International Journal of Dermatology. 45(10):1255-6, 2006.
  21. Carter JD, Vasey FB, Valeriano J. The Effect of a Low Carbohydrate Diet on Bone Turnover. Osteoporosis International. 17(9):1398-1403, 2006.
  22. Vasey FB, Carter JD. Intestinal Flora and Psoriatic Arthritis. Journal of Rheumatology. 33(10):2099, 2006.
  23. Carter, JD, Espinoza LR. The Interplay of Environment and Host Response in Reactive Arthritis: Can We Intervene? Future Rheumatology. 1(6):717-27, 2006.
  24. Carter, JD. TNF-alpha Inhibition Causing Psoriasis? A More Plausible Explanation Exists. Annals of the Rheumatic Diseases. 65(12):1680, 2006.
  25. Carter JD. Reactive Arthritis: Defined Etiologies, Emerging Pathophysiology, and Elusive Treatment. Infectious Disease Clinics of North America. 20(4):827-47, 2006.
  26. Carter JD, Lodhi A, Nagda SR, Ricca L, Ward C, Traina E, Thompson ZJ, Huang x, Valeriano J, Vasey FB. Determining Rheumatologists’ Accuracy at Assessing Functional Disability in Rheumatoid Arthritis Patients by Using the Health Assessment Questionnaire – Disability Index (HAQ-DI). Journal of Rheumatology. 34(5):958-63, 2007.
  27. Brown NA, Carter JD. Urticarial Vasulitis. Current Rheumatology Reports. 9(4):312-9, 2007.
  28. Carter JD. Functional Disability Determination of the Rheumatoid Arthritis Patient: A Failing System. Touch Briefings, US Musculoskeletal Review. Issue II:26-7, 2007.
  29. McKinley J, Vasey F, McMillen A, Carter J, Brady P. Joint Observations with Lessons for Rheumatologists and Gastroenterologists. Inflammatory Bowel Disease 14(5):730-1, 2008.
  30. Carter JD, Patel S, Sultan FL, Thompson ZJ, Hemstreet M, Sterrett A, Carney G, Murphy N, Huang Y, Valeriano J, Vasey FB. The Recognition and Treatment of Vertebral Fractures in Males with Chronic Obstructive Pulmonary Disease. Respiratory Medicine. (in press)
  31. Carter JD, Gerard HC, Hudson AP. Psoriasiform Lesions Induced by TNF Antagonists: A Skin-Deep Medical Conundrum. Annals of the Rheumatic Diseases (in press)
  32. Baag AA, Vale FL, Carter JD, Rojiani AM. An Elusive Case of Wegener’s Granulomatosis with CNS Involvement: A Neuroimaging Clinicopathologic Correlation. Journal of Neuroimaging (in press)
  33. Shetty A, Marcum C, Glass LF, Carter JD. Successful Treatment of Pemphigus Vulgaris with the TNF-alpha Antagonist Etanercept in 4 Patients. Journal of the American Academy of Dermatology (submitted)

 

▲ Back to Top

Published Books or Book Chapters

  1. Carter JD. Methotrexate. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:199-205.
  2. Carter JD. Hydroxychloroquine. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:205-8.
  3. Carter JD. Calcitonin. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:229-33.
  4. Carter JD. Leflunomide. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:210-4.
  5. Carter JD. Etanercept. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:214-20.
  6. Carter JD. Infliximab. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:220-3.
  7. Carter JD. Adalimumab. In Adelman HM. Rheumatology Questions and Answers. Merit Publishing International. Surrey, England. 2008:223-6.
  8. Guthrie JP, Carter JD. Reactive Arthritis (a monograph written for an online textbook). British Medical Journal Publishing; London, England. (in press)

 

▲ Back to Top

Abstracts Presented/Published

  1. Carter JD, Mills CR, Valeriano J, Kanik KS and Vasey FB: Preliminary 6 month results of a prospective comparison of doxycycline vs. doxycycline and rifampin in undifferentiated spondyloarthritis. Arthritis and Rheumatism. 44(9 supplement):S92(235),2001. American College of Rheumatology National Convention; San Francisco, CA; October 22, 2001. University of South Florida Research Day; Tampa, FL; February 24, 2002.
  2. Valeriano-Marcet J, Johnson T, Lowenstein M, Dacchille B, Stephenson A, Carter JD, Vasey FB: Osteoporosis Risk Assesment Tool (ORAT) Assists Clinicians in Selecting Postmenopausal Women for DXA Testing. ASBMR 25th Annual Meeting, September 19-23, 2003.
  3. Kirzhner I, Howell T, Rhee D, Warman M, Sandy J, Carter JD, Plaas A. Disulfide Bonded Multimers of Lubricin in Normal Synovial Fluid – Synthesis and Assembly by Synovial Lining Cells. Cartilage Innovation Summit; Cleveland Clinic, May 2005.
  4. Lodhi A, Valeriano J, Vasey FB, Carter JD. Rheumatologists’ Ability to Predict Functional Disability in Rheumatoid Arthritis Patients by Using the Health Assessment Questionnaire (HAQ). American College of Rheumatology National Convention, San Diego, CA; November 11-17, 2005. University of South Florida Research Day, Tampa, FL; February 23, 2006
  5. Brown NA, Vasey FB, Carter JD. TNF-alpha Antagonists and the Induction of Autoantibodies. University of South Florida Research Day, Tampa, FL; February 23, 2007. Rheumatology on the Beach, Destin, FL; March 28, 2007.
  6. Guthrie JP, Oszust C, Hudson AP, Carter JD. CCR-5 Delta 32 Mutation and its Relationship to the Development of Chlamydia-Induced Reactive Arthritis. Rheumatology on the Beach, Destin, FL; March 28, 2007.
  7. Carter JD, Espinoza LR, Inman RD, Seleznick M, Sneed K, Ricca L, Valeriano J, Vasey FB, Oszust C, Snelgrove J, Hudson AP. An Evaluation of the Utility of PBMC PCR Testing for Chlamydia in Subjects with Suspected Chronic Chlamydia-Induced Reactive Arthritis. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007. ARTHRITIS RHEUM 2007;Vol.56, No.9:S540. (Accepted as a Presentation at Concurrent Session).
  8. Carter JD, Espinoza LR, Inman RD, Seleznick M, Sneed K, Ricca L, Valeriano J, Vasey FB, Oszust C, Snelgrove J, Gerard H, Hudson AP. A Comparison of the Phenotypic Manifestations of Chlamydia trachomatis vs. Chlamydophila pneumoniae-Induced Reactive Arthritis. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007. ARTHRITIS RHEUM 2007;Vol.56, No.9:S541. (Accepted as a Presentation at Concurrent Session).
  9. Carter JD, Ladhani A, Ricca L, Valeriano J, Vasey FB. A Safety Assessment of the TNF Antagonists During Pregnancy: A Review of the FDA Database. An Evaluation of Predictive Factors. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007. ARTHRITIS RHEUM 2007;Vol.56, No.9:S286. (Accepted as a Presentation at Plenary Session I).
  10. Hudson AP, Oszust C, Guthrie JP, Whittum-Hudson JA, Snelgrove J, Carter JD, Schumacher HR, Gerard HC. Functional CCR5 Receptor Protects From High Synovial Chlamydia trachomatis Burden but Differentially Protects Against Induction of Inflammatory Arthritis in ReA and UO Patients. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007. ARTHRITIS RHEUM 2007;Vol.56, No.9:S619.
  11. Hudson AP, Schumacher HR, Whittum-Hudson JA, Carter JD, Gerard HC. Patients Infected with Chlamydia Trachomatis Frequently Have Ocular, Not Genital, Serovars of the Organism in the Synovial Tissue. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007. ARTHRITIS RHEUM 2007;Vol.56, No.9:S619.
  12. Beg H, Carter JD, Vasey FB, Valeriano J. Long-Term Follow Up of Combination Antimicrobial Therapy for Chlamydia-Induced ReA. 71st American College of Rheumatology National Annual Scientific Meeting. Boston, MA, November 6-11, 2007.

 

▲ Back to Top